VIS Containers Manufacturing SA
ATHEX:VIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
VIS Containers Manufacturing SA
ATHEX:VIS
|
GR |
|
BHG Group AB
STO:BHG
|
SE |
|
M
|
Moneysupermarket.Com Group PLC
OTC:MNSKY
|
UK |
|
Dorel Industries Inc
F:DO4C
|
CA |
|
SeaChange International Inc
OTC:SEAC
|
US |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
KR |
|
W-Scope Corp
TSE:6619
|
JP |
|
BiVictriX Therapeutics PLC
LSE:BVX
|
UK |
Balance Sheet
Balance Sheet Decomposition
VIS Containers Manufacturing SA
VIS Containers Manufacturing SA
Balance Sheet
VIS Containers Manufacturing SA
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
12
|
11
|
12
|
12
|
9
|
7
|
4
|
5
|
5
|
4
|
|
| Accounts Receivables |
11
|
10
|
11
|
11
|
8
|
6
|
3
|
4
|
4
|
4
|
|
| Other Receivables |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Inventory |
5
|
4
|
4
|
3
|
3
|
3
|
4
|
3
|
4
|
3
|
|
| Total Current Assets |
17
|
15
|
16
|
15
|
12
|
10
|
7
|
8
|
8
|
7
|
|
| PP&E Net |
22
|
21
|
21
|
20
|
19
|
19
|
18
|
18
|
23
|
22
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
|
| Total Assets |
42
N/A
|
40
-7%
|
39
0%
|
38
-5%
|
34
-9%
|
31
-8%
|
28
-9%
|
28
-1%
|
33
+18%
|
30
-8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
3
|
|
| Short-Term Debt |
7
|
2
|
3
|
4
|
4
|
4
|
3
|
4
|
5
|
3
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
7
|
1
|
|
| Other Current Liabilities |
3
|
4
|
4
|
4
|
3
|
3
|
4
|
4
|
5
|
6
|
|
| Total Current Liabilities |
14
|
11
|
12
|
12
|
12
|
12
|
12
|
14
|
22
|
13
|
|
| Long-Term Debt |
7
|
11
|
10
|
9
|
9
|
8
|
8
|
7
|
0
|
6
|
|
| Deferred Income Tax |
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
|
| Other Liabilities |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
6
|
|
| Total Liabilities |
28
N/A
|
27
-2%
|
28
+1%
|
27
-3%
|
26
-3%
|
26
-1%
|
25
-3%
|
27
+8%
|
30
+11%
|
27
-8%
|
|
| Equity | |||||||||||
| Common Stock |
14
|
14
|
14
|
14
|
14
|
14
|
4
|
4
|
3
|
3
|
|
| Retained Earnings |
0
|
2
|
2
|
3
|
6
|
9
|
1
|
3
|
3
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Total Equity |
14
N/A
|
12
-15%
|
12
-2%
|
11
-9%
|
8
-24%
|
6
-32%
|
3
-39%
|
1
-70%
|
3
+202%
|
3
-5%
|
|
| Total Liabilities & Equity |
42
N/A
|
40
-7%
|
39
0%
|
38
-5%
|
34
-9%
|
31
-8%
|
28
-9%
|
28
-1%
|
33
+18%
|
30
-8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
5
|
41
|
41
|
41
|
41
|
41
|
41
|
55
|
55
|
|